174 related articles for article (PubMed ID: 35552463)
1. Functional in-vitro evaluation of the non-specific effects of BCG vaccination in a randomised controlled clinical study.
Wilkie M; Tanner R; Wright D; Lopez Ramon R; Beglov J; Riste M; Marshall JL; Harris SA; Bettencourt PJG; Hamidi A; van Diemen PM; Moss P; Satti I; Wyllie D; McShane H
Sci Rep; 2022 May; 12(1):7808. PubMed ID: 35552463
[TBL] [Abstract][Full Text] [Related]
2. Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial.
Tameris M; Mearns H; Penn-Nicholson A; Gregg Y; Bilek N; Mabwe S; Geldenhuys H; Shenje J; Luabeya AKK; Murillo I; Doce J; Aguilo N; Marinova D; Puentes E; Rodríguez E; Gonzalo-Asensio J; Fritzell B; Thole J; Martin C; Scriba TJ; Hatherill M;
Lancet Respir Med; 2019 Sep; 7(9):757-770. PubMed ID: 31416768
[TBL] [Abstract][Full Text] [Related]
3. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
4. Bacille Calmette-Guérin vaccination to prevent febrile and respiratory illness in adults (BRACE): secondary outcomes of a randomised controlled phase 3 trial.
Pittet LF; Messina NL; McDonald E; Orsini F; Barry S; Bonten M; Campbell J; Croda J; Croda MG; Dalcolmo M; Gardiner K; Gwee A; Jardim B; Lacerda MVG; Lucas M; Lynn DJ; Manning L; Perrett KP; Post JJ; Prat-Aymerich C; Richmond PC; Rocha JL; Rodriguez-Baño J; Warris A; Wood NJ; Davidson A; Curtis N;
EClinicalMedicine; 2024 Jun; 72():102616. PubMed ID: 38774675
[TBL] [Abstract][Full Text] [Related]
5. Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial.
Spertini F; Audran R; Chakour R; Karoui O; Steiner-Monard V; Thierry AC; Mayor CE; Rettby N; Jaton K; Vallotton L; Lazor-Blanchet C; Doce J; Puentes E; Marinova D; Aguilo N; Martin C
Lancet Respir Med; 2015 Dec; 3(12):953-62. PubMed ID: 26598141
[TBL] [Abstract][Full Text] [Related]
6. Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85A.
Tanner R; Kakalacheva K; Miller E; Pathan AA; Chalk R; Sander CR; Scriba T; Tameris M; Hawkridge T; Mahomed H; Hussey G; Hanekom W; Checkley A; McShane H; Fletcher HA
BMC Infect Dis; 2014 Dec; 14():660. PubMed ID: 25466778
[TBL] [Abstract][Full Text] [Related]
7. Circadian rhythm influences induction of trained immunity by BCG vaccination.
de Bree LCJ; Mourits VP; Koeken VA; Moorlag SJ; Janssen R; Folkman L; Barreca D; Krausgruber T; Fife-Gernedl V; Novakovic B; Arts RJ; Dijkstra H; Lemmers H; Bock C; Joosten LA; van Crevel R; Benn CS; Netea MG
J Clin Invest; 2020 Oct; 130(10):5603-5617. PubMed ID: 32692732
[TBL] [Abstract][Full Text] [Related]
8. Bacille Calmette-Guérin vaccination at birth and differential white blood cell count in infancy. A randomised clinical trial.
Jensen SK; Jensen TM; Birk NM; Stensballe LG; Benn CS; Jensen KJ; Pryds O; Jeppesen DL; Nissen TN
Vaccine; 2020 Mar; 38(11):2449-2455. PubMed ID: 32057570
[TBL] [Abstract][Full Text] [Related]
9. Historical BCG vaccination combined with drug treatment enhances inhibition of mycobacterial growth ex vivo in human peripheral blood cells.
Prabowo SA; Zelmer A; Stockdale L; Ojha U; Smith SG; Seifert K; Fletcher HA
Sci Rep; 2019 Mar; 9(1):4842. PubMed ID: 30890730
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.
Fletcher HA; Tanner R; Wallis RS; Meyer J; Manjaly ZR; Harris S; Satti I; Silver RF; Hoft D; Kampmann B; Walker KB; Dockrell HM; Fruth U; Barker L; Brennan MJ; McShane H
Clin Vaccine Immunol; 2013 Nov; 20(11):1683-9. PubMed ID: 23986316
[TBL] [Abstract][Full Text] [Related]
11. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
[TBL] [Abstract][Full Text] [Related]
12. Bacille Calmette-Guérin (BCG) vaccination at birth and antibody responses to childhood vaccines. A randomised clinical trial.
Nissen TN; Birk NM; Smits G; Jeppesen DL; Stensballe LG; Netea MG; van der Klis F; Benn CS; Pryds O;
Vaccine; 2017 Apr; 35(16):2084-2091. PubMed ID: 28318766
[TBL] [Abstract][Full Text] [Related]
13. Polyfunctional CD4 T-cells correlate with in vitro mycobacterial growth inhibition following Mycobacterium bovis BCG-vaccination of infants.
Smith SG; Zelmer A; Blitz R; Fletcher HA; Dockrell HM
Vaccine; 2016 Oct; 34(44):5298-5305. PubMed ID: 27622301
[TBL] [Abstract][Full Text] [Related]
14. Vaccination strategies to prevent tuberculosis in the new millennium: from BCG to new vaccine candidates.
Franco-Paredes C; Rouphael N; del Rio C; Santos-Preciado JI
Int J Infect Dis; 2006 Mar; 10(2):93-102. PubMed ID: 16377228
[TBL] [Abstract][Full Text] [Related]
15. BCG vaccination in humans inhibits systemic inflammation in a sex-dependent manner.
Koeken VA; de Bree LCJ; Mourits VP; Moorlag SJ; Walk J; Cirovic B; Arts RJ; Jaeger M; Dijkstra H; Lemmers H; Joosten LA; Benn CS; van Crevel R; Netea MG
J Clin Invest; 2020 Oct; 130(10):5591-5602. PubMed ID: 32692728
[TBL] [Abstract][Full Text] [Related]
16. The introduction of BCG vaccination to neonates in Northern Sweden, 1927-31: Re-analysis of historical data to understand the lower mortality among BCG-vaccinated children.
Schaltz-Buchholzer F; Kjær Sørensen M; Benn CS; Aaby P
Vaccine; 2022 Mar; 40(11):1516-1524. PubMed ID: 34134904
[TBL] [Abstract][Full Text] [Related]
17. Lack of a Negative Effect of BCG-Vaccination on Child Psychomotor Development: Results from the Danish Calmette Study - A Randomised Clinical Trial.
Kjærgaard J; Stensballe LG; Birk NM; Nissen TN; Foss KT; Thøstesen LM; Pihl GT; Andersen A; Kofoed PE; Pryds O; Greisen G
PLoS One; 2016; 11(4):e0154541. PubMed ID: 27123570
[TBL] [Abstract][Full Text] [Related]
18. BCG Vaccination of Infants Confers
Subbian S; Singh P; Kolloli A; Nemes E; Scriba T; Hanekom WA; Kaplan G
ACS Infect Dis; 2020 Dec; 6(12):3141-3146. PubMed ID: 33226778
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B vaccine co-administration influences the heterologous effects of neonatal BCG vaccination in a sex-differential manner.
Pittet LF; Cox L; Freyne B; Germano S; Bonnici R; Gardiner K; Donath S; Collins CL; Casalaz D; Robins-Browne R; Flanagan KL; Messina NL; Curtis N
Vaccine; 2022 Feb; 40(9):1334-1341. PubMed ID: 35105495
[TBL] [Abstract][Full Text] [Related]
20. Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial.
Hoft DF; Blazevic A; Selimovic A; Turan A; Tennant J; Abate G; Fulkerson J; Zak DE; Walker R; McClain B; Sadoff J; Scott J; Shepherd B; Ishmukhamedov J; Hokey DA; Dheenadhayalan V; Shankar S; Amon L; Navarro G; Podyminogin R; Aderem A; Barker L; Brennan M; Wallis RS; Gershon AA; Gershon MD; Steinberg S
EBioMedicine; 2016 May; 7():278-86. PubMed ID: 27322481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
